Cardiovascular Toxicology, Third Edition

1. Cardiovascular Toxicology: Introductory Remarks R. Melchert, C. Yuan and D. Acosta 2. Acute and Chronic Testing of the Cardiovascular Toxicology of Drugs: An Industrial Perspective S. Gad 3. Evaluation of In Vitro Cytotoxicity Modeling R. Chacon, J. Bond and J. Lemasters 4. Assessment of Cardiovascular Function in Conscious Animals T. Patrick, A. Kucky, Y. Shen and K. Asai 5. Cell Injury and Cell Death: Apoptosis, Oncosis and Necroses B. Trump, S. Chang, P. Phelps and R. Jones 6. Pathobiology of Myocardial Ischemic Injury L. Buja 7. Cardiovascular Toxicity of Antibacterial Antibiotics H. Adams, J. Kerzee, K. Ramos and J. Parker 8. Lipopolysaccharides (Entoxin) and Myocardial Dysfunction L. Rubin, H. Adams and J. Parker 9. Cardiotoxicity of Catecholamines and Related Agents N. Dhalla, H. Sasaki, K. Dhalla, X. Liu, V. Elimban and S. Machisuki 10. Cardiotoxicity of CNS Acting Drugs and Chemicals K. Skau 11. Action of Cardiotoxic Agents on Ion Channels and Pumps N. Sperelakis, M. Sunagawa, M. Nakamura, H.Yokoshiki and T. Seki 12. Cardiotoxicity of Anthracyclines and Other Related Antineoplastics J. Pruemer 13. Passive Smoking Causes Heart Disease S. Glantz 14. Cardiovascular Effects of Steroidal Agents R. Melchert and R. Kennedy 15. Vascular Toxicology: A Cellular and Molecular Perspective K. Ramos, J. Kerzee, N. Alejandro and K. Lu 16. Pathobiology of the Vascular Response to Injury P. Anderson, Z. Ruben and B. Wagner 17. Medial Injury of Large and Elastic Blood Vessels P. Boor NIEHS, USA, D. Acosta, University of Cincinnati, USA, S. Gad, Gad Consulting Services, USA, R. Chacon, Cedra Corp, USA, J. Bond, Riverside Veterinary Hospital, USA, J. Lemasters, University of North Carolina, USA, T. Patrick, Penn State University, USA, A. Kucky, Penn State University, USA, Y. Shen, Penn State University, USA, K. Asai, Penn State University, USA, B. Trump, Warwick Research Institute, USA, S. Chang, University of Maryland, USA, P. Phelps, University of Maryland, USA, R. Jones, University of Maryland, USA, L. Buja, University of Texas, USA, H. Adams, Texas A&M University, USA, J. Kerzee, Texas A&M University, USA, K. Ramos, Texas A&M University, USA, J. Parker, Texas A&M University, USA, L. Rubin, University of Missouri, USA, N. Dhalla, University of Manitoba, Canada, H. Sasaki, University of Manitoba, Canada, K. Dhalla, University of Manitoba, Canada, X. Liu, University of Manitoba, Canada, V. Elimban, University of Manitoba, Canada, S. Machisuki, Jikei University School of Medicine, K. Skau, University of Cincinnati, USA, N. Sperelakis, University of Cincinnati, USA, M. Sunagawa, University of Cincinnati, USA, M. Nakamura, University of Cincinnati, USA, H. Yokoshiki, University of Cincinnati, USA, T. Seki, University of Cincinnati, USA, J. Pruemer, University Hospital, Cincinnati, USA, S. Glantz, University of California at San Francisco, USA, R. Kennedy, University of Arkansas, USA, N. Alejandro, Texas A&M University, USA, K. Lu, Texas A&M University, USA, P. Anderson, University of Alabama, USA, Z. Ruben, Patoximed Consultants, USA, B. Wagner, Short Hills, USA, P. Boor, University of Texas, USA.